Biotech Pre-Seed Investors & VC Firms
915 firms in this list, with a median first check of $250K. 237 of them lead rounds. Generated from verified public data and updated continuously.
UTokyo Innovation Platform Co. Ltd.
TokyoPre-Seed–Growth
21 people
Rev1 Ventures
ColumbusPre-Seed–Series A
53 people
South Park Commons
San FranciscoPre-Seed–Late Stage$1M – $10M
13 people
HTGF
BonnPre-Seed–Series A$1.1M
37 people
Nazca
Mexico CityPre-Seed–Late Stage
32 people
UC Berkeley Skydeck
BerkeleyPre-Seed–Seed$200K
59 people
OUP (Osage University Partners)
Bala CynwydPre-Seed–Late Stage$1M – $20M
21 people
Golden Ventures
TorontoPre-Seed–Series A$500K – $2.5M
9 people
Innovation Works
PittsburghPre-Seed–Seed$100K – $300K
44 people
Innovation UBC
VancouverPre-Seed–Seed
46 people
NLC
AmsterdamPre-Seed–Seed
43 people
Perot Jain
DallasPre-Seed–Series A$500K
4 people
ZhenFund
BeijingPre-Seed–Series A$250K – $3M
36 people
b2venture
BerlinPre-Seed–Series B$270K – $5.4M
36 people
2048 Ventures
New YorkPre-Seed–Seed$500K – $3M
21 people
Manta Ray Ventures
LondonPre-Seed–Growth
8 people
Chalmers Ventures AB
GöteborgPre-Seed–Series A$21.6M
24 people
GoAhead Ventures
Menlo ParkPre-Seed–Seed$500K – $1M
12 people
The Innovation Space
WilmingtonPre-Seed–Seed$200K
31 people
Dolby Family Ventures
San FranciscoPre-Seed–Series A
20 people
0BS
MexicoPre-Seed–Seed$50K – $150K
45 people
Cambridge Angels group
CambridgePre-Seed–Series A$195K – $1.9M
5 people
Forbion
NaardenPre-Seed–Late Stage
25 people
Heartfelt Capital
BerlinPre-Seed–Seed$110K – $440K
4 people
Related lists
Pre-Seed Investors & VC Firms (5569)Pre-Seed Investors & VC Firms in North America (3004)Pre-Seed Investors & VC Firms in United States (2671)Biotech Investors & VC Firms (2475)AI & Machine Learning Pre-Seed Investors & VC Firms (2102)Biotech Seed Investors & VC Firms (2020)Fintech Pre-Seed Investors & VC Firms (1711)SaaS Pre-Seed Investors & VC Firms (1652)Biotech Series A Investors & VC Firms (1626)Pre-Seed Investors & VC Firms in Europe (1598)
Data sourced from public filings and firms' own websites — see our methodology.














































































































